Correlation Between Cullinan Oncology and Aslan Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Aslan Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Aslan Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Aslan Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Aslan Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Aslan Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Aslan Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Aslan Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cullinan and Aslan is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Aslan Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aslan Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Aslan Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aslan Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Aslan Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Aslan Pharmaceuticals
If you would invest (100.00) in Aslan Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 100.00 from holding Aslan Pharmaceuticals or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Aslan Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Aslan Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cullinan Oncology and Aslan Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Aslan Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Aslan Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Aslan Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will offset losses from the drop in Aslan Pharmaceuticals' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Aslan Pharmaceuticals vs. Monte Rosa Therapeutics | Aslan Pharmaceuticals vs. NewAmsterdam Pharma | Aslan Pharmaceuticals vs. Inventiva Sa | Aslan Pharmaceuticals vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |